Zobrazeno 1 - 10
of 8 337
pro vyhledávání: ''
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 22:64-70
Background: The link between bilirubin and cardiometabolic outcomes has been previously identified with positive health effects of mild hyperbilirubinaemia. On the other hand, recent evidence has suggested an association between low circulating bilir
Autor:
Jesus D. Melgarejo, Silvia Stringhini, Belen Ponte, Idris Guessous, Zhenyu Zhang, Bruno Vogt, Pierre-Yves Martin, Murielle Bochud, Daniel Ackermann, Georg Ehret, Nicolas Ansermot, Menno Pruijm, Chin B. Eap, Nasser A. Dhayat, Jan A. Staessen, Lutgarde Thijs, Sandrine Estoppey-Younès, Dusan Petrovic
Publikováno v:
Mayo Clinic Proceedings. 96:3071-3085
Objective To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries. Methods Families were randomly selected from the general population of northern
Autor:
Burcin Meryem Atak Tel, Gulali Aktas, Tuba Taslamacioglu Duman, Buse Balci, Asli Erturk, Ozge Kurtkulagi, Satilmis Bilgin, Gizem Kahveci
Publikováno v:
Romanian Journal of Internal Medicine, Vol 59, Iss 4, Pp 403-408 (2021)
Background. Hashimoto’s thyroiditis (HT) is an auto-immune condition characterized with lymphocytic and fibroblastic infiltration of the thyroid gland. The rate of uric acid and HDL cholesterol – so called as uric acid to HDL ratio (UHR) has been
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 12, Pp 2203-2211 (2021)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Few people have reported whether there are sex differences in blood lipids and lipid ratios in type 2 diabetic foot (T2DF) patients in China. This study attempts to identify the contribution to sex‐specific differences in blood li
Autor:
Yingling Zhou, Haojian Dong, Wei Li, Haoyu Lu, Chenyang Wang, Guang Li, Haotian Zhang, Xiangming Hu
Publikováno v:
Journal of Diabetes Research
Journal of Diabetes Research, Vol 2021 (2021)
Journal of Diabetes Research, Vol 2021 (2021)
Background. Diabetes mellitus (DM) and dyslipidemia are the main risk factors for atherosclerosis. Elevated glycosylated hemoglobin A1c (HbA1c) and reduced high-density lipoprotein cholesterol (HDL-C) are associated with the progression of atheroscle
Publikováno v:
Biomarkers in Medicine. 15:1367-1375
Aim: The present study evaluates the relationship between the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) and the percentage of excess weight loss (%EWL) in patients undergoing laparoscopic sleeve gastrectomy. Method: This prospectiv
Autor:
Dinesh Kadariya, Salvatore Carbone, Hayley Billingsley, Richard H. Cooke, Antonio Abbate, Benjamin W. Van Tassell, Cory R. Trankle, Dave L. Dixon, Justin M. Canada, Linda Hart
Publikováno v:
J Cardiovasc Pharmacol
The sodium glucose co-transporter 2 inhibitors have demonstrated favorable effects on cardiovascular and renal disease; however, they may also increase low-density lipoprotein cholesterol (LDL-C). There are limited data directly comparing the effects
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-11 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Limited data are available for validation of low-density lipoprotein cholesterol (LDL) calculation (LDLcal) in the adult Korean population. The aim of this study was to develop and validate a new equation for LDLcal and to compare it with
Autor:
Janice Campbell, Maike Rahn, Adish Ezatagha, Susan E Spruill, YiFang Chu, Elhadji M. Dioum, Alexandra L Jenkins, Thomas M.S. Wolever
Publikováno v:
The Journal of Nutrition. 151:2655-2666
Background High-molecular-weight (MW) oat β-glucan (OBG), consumed at 3-4 g/d, in solid foods reduces LDL cholesterol by a median of ∼6.5%. Objectives We evaluated the effect of a beverage providing 3 g/d high-MW OBG on reduction of LDL cholestero
Autor:
Ruth Frikke-Schmidt, Christie M. Ballantyne, Seth S. Martin, Peter W.F. Wilson, Alan T. Remaley, Terry A. Jacobson, Elizabeth A. Jackson, Michael H. Davidson, N-Anh Le, Hubert W. Vesper
Publikováno v:
Journal of Clinical Lipidology. 15:629-648
Lipoprotein measurements are pivotal in the management of patients at risk for atherosclerotic coronary heart disease (CHD) with myocardial infarction and coronary death as the main outcomes, and for atherosclerotic cardiovascular disease (ASCVD), wh